These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34742033)

  • 1. High S100A7 expression is associated with early muscle invasion and poor survival in bladder carcinoma.
    Dong Y; Zhu GY; Hao L; Liang Q; Zhou JH; Shi ZD; Yu H; Ma WM; Fan T; Zhang WD; Zang GH; Han CH
    Ann Diagn Pathol; 2022 Feb; 56():151847. PubMed ID: 34742033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
    Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCGA Database-Based Screening of Tumor Microenvironment Immunomodulators Related to Bladder Cancer Prognosis.
    Ye JN; Gan MP; Wu XL; Dong Z; Mai HH
    Ann Clin Lab Sci; 2024 May; 54(3):299-312. PubMed ID: 39048164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.
    Liu J; Zhao Z; Sun Z; Liu C; Cheng X; Ruge F; Yang Y; Jiang WG; Ye L
    Oncol Rep; 2020 Feb; 43(2):562-570. PubMed ID: 31894335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
    Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
    Shen P; He X; Lan L; Hong Y; Lin M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Yang D; Ma Y; Zhao P; Ma J; He C
    Biomed Pharmacother; 2019 Dec; 120():109433. PubMed ID: 31568988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Bi D; Ning H; Liu S; Que X; Ding K
    Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
    Jin K; Qiu S; Jin D; Zhou X; Zheng X; Li J; Liao X; Yang L; Wei Q
    Aging (Albany NY); 2021 Jan; 13(2):1859-1871. PubMed ID: 33465047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
    Chen Q; Hu J; Deng J; Fu B; Guo J
    Biomed Res Int; 2019; 2019():3917982. PubMed ID: 31828101
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mRNA expression differences in bladder cancer metastasis based on TCGA datasets.
    Liu S; Shi J; Liu Y; Wang L; Zhang J; Huang Y; Chen Z; Yang J
    J Int Med Res; 2021 Mar; 49(3):300060521996929. PubMed ID: 33787386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
    Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.